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central Scandinavia: differences between Norway and 
Sweden 
M. SIJE-CHU*$, L. LARSSON~. AND L. BJERMJZR* 
*Department of Lung Medicine, University Hospital, Trondheim, Norway, and TDepartment of Pulmonary 
Medicine, iistersund Hospital, &tersund, Sweden 
An increased prevalence of asthma in cross-country skiers has been reported previously. This study was 
conducted in order to evaluate the prevalence of asthma among young, elite cross-country skiers in Trsndelag, 
Norway and Jamtland, Sweden. These two regions in central Scandinavia have different climates during the 
winter season, with a coastal type in Trsndelag while Jamtland is characterized by a colder, drier, inland type 
of climate. The study population consisted of 171 skiers (118 from Norway, 53 from Sweden). The 
investigation included an asthma questionnaire, spirometry and methacholine provocation testing. The 
prevalence of self-reported asthma-related symptoms was 46% in Norway and 5 1% in Sweden. The prevalence 
of bronchial hyper-responsiveness (BHR) was significantly different between the two regions. In Norway, 14% 
of the skiers were hyper-responsive to methacholine compared to 43% in Sweden (P<O.OOl). Moreover, the 
estimated prevalence of clinically diagnosed asthma was 12% in Norway and 42% in Sweden (P<O.OOl). 
The self-reported frequency of respiratory allergy was higher in Sweden (32%) than in Norway (11%). 
However, on an individual basis, self-reported allergy did not predict occurrence of asthma or BHR. In 
conclusion, there is a high prevalence of BHR and asthma among young, elite cross-country skiers in central 
Scandinavia, especially in Sweden. Cross-country skiing may be a risk factor for the development of asthma. 
Longitudinal studies of cross-country skiers, and studies to acquire further knowledge of the mechanisms 
involved in the development of asthma are indicated. 
Introduction 
Physical exercise and the inhalation of cold, dry air 
can provoke acute bronchoconstriction in susceptible 
individuals. Competitive cross-country skiers per- 
form sustained, strenuous exercise during which they 
inhale large volumes of cold air, often at tempera- 
tures below - 15°C. Obstructive airway symptoms 
and asthma are 2-6 times more common among 
competitive cross-country skiers in Norway (1) and 
Sweden (2,3) than in the normal population. How- 
ever, due to differences in methodology, it is not 
possible to directly compare the findings in these 
studies. Furthermore, a persistent increase in 
bronchial responsiveness has been reported in elite 
Swedish skiers. It has been proposed that strenuous 
training at low temperatures with the repeated 
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inhalation of large amounts of cold air may be 
asthmagenic (2). 
In central Scandinavia, the neighbouring counties 
of Trondelag in Norway and Jamtland in Sweden 
have different winter climates. The former, because of 
its coastal location, has milder winters than the latter, 
which has an inland climate with colder, drier air in 
the winter. This study was designed in order to 
compare the prevalence of asthma symptoms, bron- 
chial hyper-responsiveness (BHR) and asthma in 
young, competitive cross-country skiers from the two 
regions. 
Materials and Methods 
STUDY POPULATION (TABLE 1) 
The study population consisted of 171 young, elite 
cross-country skiers, who were attending senior sec- 
ondary schools in Norway (118 skiers) and Sweden 
(38 skiers), or serving as conscripted soldiers in a 
Swedish military ski-platoon (15 skiers). There were 
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Table I Characteristics of subjects 
Senior secondary school students: 
Military service skiers: 
Norway 
118 
Sweden 
38 
15 
Number 
Sex 
male 
female 
Age (years) mean (SD) 
Training mean (range) 
(h in the previous yr) 
Competition (yr) mean (range) 
FEV, (1) mean (SD) 
% of predicted FEV, mean (SD) 
FVC (1) mean (SD) 
% of predicted FVC mean (SD) 
118 53 
90 (76%) 36 (68%) 
28 (24%) 17 (32%) 
17.0 (1.1) 18.4 (1.4)*** 
400 ( 100-700) 428 (250-600) 
7.4 (2-13) 8.6 (5-13)** 
4.24 (0.64) 4.32 (0.68) 
100.1 (10.3) 98.7 (11.3) 
4.92 (0.86) 4.84 (0.82) 
98.3 (10.7) 95.2 (10.4) 
**p<o.o1, ***P<o.ool. - 
no current smokers. There was a preponderance of 
male skiers in both groups. The mean age (18.4 vs. 
17.0 years, P<O.OOl) and mean number of years of 
competition (8.6 vs. 7.4 yr, PcO.01) were significantly 
greater in the Swedish skiers. There was no signifi- 
cant difference in the mean training hours during the 
previous year. Spirometry was normal in both groups 
with no significant differences between the groups. 
All subjects, as well as the parents of those subjects 
under 18 years of age, gave written informed consent, 
and the study was approved by the Regional Ethics 
Committee in Trondheim. 
QUESTIONNAIRE 
All subjects completed a questionnaire in their 
native language. Each skier was asked to estimate the 
time spent in training during the previous year and 
the number of years of competition. The question- 
naire also included questions about known respira- 
tory allergy, cigarette smoking, medical consultations 
within the last 5 yr for respiratory symptoms, and 
physician diagnosis of asthma. Each skier was asked 
about the use of anti-asthmatic medication and the 
presence within the last year of respiratory symp- 
toms, such as cough, attacks of shortness of breath, 
chest tightness and wheezing. It was also determined 
whether these symptoms were present on exercise, or 
on exposure to cold conditions and irritants. 
LUNG FUNCTION 
Lung function (FEV,, FVC, and percentage of 
their predicted values) in each subject was assessed 
by spirometry using a Microlab 3300 Mk2 spiro- 
meter (Micro Medical Ltd). The better of two 
measurements with less than 5% variation was 
recorded. 
BRONCHIAL HYPER-RESPONSIVENESS (BHR) 
The bronchial responsiveness of each subject to 
methacholine was assessed by a controlled tidal vol- 
ume breathing technique (4). The Spira Elektro 2 
automatic inhalation synchronized dosimeter jet 
nebulizer (Respiratory Care Centre, Hameenlinna, 
Finland) was used. The nebulization time was 0.5 s, 
starting after the inhalation of 100 ml of the tidal 
volume. For each inhalation, the inspiratory flow 
rate did not exceed 0.5 1 s ~ ’ and the inspired vol- 
ume was at least 0.5 1. The mean (SD) output of 
the nebulizer, determined by five weighings on a 
gravimetric balance, was 5.0 (0.5) ,~l inhalation - ‘. 
Bronchodilators were withheld on the day of 
investigation. Each skier practised with the dosi- 
meter before the start of the test. Baseline spirom- 
etry after the inhalation of 0.9% saline was 
performed initially. 
Methacholine concentrations of 2.5 mg ml - i and 
25 mg ml- ’ were used. A cumulative dose of 1800,~g 
(9.1 pmol) methacholine was administered in four 
stages-four and 11 inhalations of methacholine 
2.5 mg ml - ‘, followed by three and 10 inhalations of 
methacholine 25 mg ml - ‘. FEV, was measured 90 s 
after the completion of each of the first three stages 
and 180 s after the final stage. The better of two 
measurements with less than 5% variation was 
recorded. The test was stopped if the FEV, fell by 
20% or more, relative to baseline FEV,. Subjects with 
a PD,, FEV, of I 1800 pg (9.1 pmol) methacholine 
were considered to have BHR. 
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Table 2 Questionnaire results 
Norway Sweden 
(n=118) (n=53) 
(“4 (“/I 
Asthma symptoms Abnormal shortness of breath on exertion 30 26 
Breathlessness at rest 6 6 
Breathlessness on exposure to tobacco smoke, 31 40 
strong scents, dusty or humid air 
Wheeze within the last year 45 47 
Chest tightness on exertion within the last year 39 38 
Chest tightness without exertion within the 
last year 9 19 
Cough Abnormal cough 4 9 
Periodic dry cough 2 4 
Cough on training in summer 10 9 
Cough on training in winter 42** 64 
Cold exposure Exacerbation of symptoms 14*** 45 
Positive answers (%) to questions about: Asthma symptoms (shortness of breath, wheeze, chest 
tightness); cough; and effect of cold conditions. 
60 
Asthma m BHR 
SYmPtomatology I Current asthma 
cl Total asthma 
50 *** 
8 42 40 
g 
1 30 
2 2 20 
10 
NS NS NS NS NS 
Fig I Prevalences (%) of self-reported respiratory allergy, asthma symptomatology, bronchial hyper-responsiveness 
(BHR), current asthma and total asthma in Norwegian (N) and Swedish (S) cross-country skiers, **P<O.Ol; 
***P<o.ool. 
POSITIVE ASTHMA SYMPTOMATOLOGY 
This was defined as the presence of both of the 
following respiratory symptoms: wheeze within the 
last year; and abnormal breathlessness or chest tight- 
ness present within the last year either on exertion, at 
rest, or on exposure to irritants. 
Current asthma was defined as the presence of 
positive asthma symptomatology and BHR at the 
time of investigation. Total asthma was defined as 
current asthma in addition to physician-diagnosed 
asthma currently treated with steroids. 
Statistical Analysis 
Differences in age, training hours, years of 
competition and spirometry were analysed for 
statistical significance using the Student’s t-test. 
Differences in other variables were analysed 
for statistical significance using the chi-square 
test (two-tailed p, Fisher’s exact test when 
appropriate). PgO.05 was considered to be 
statistically significant (*P<O.O5, **PSO.Ol, 
***P<o.ool). 
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Table 3 Association of cough on winter training and exacerbation of symptoms on cold 
exposure with asthma symptomatology, bronchial hyper-responsiveness and current asthma in 
Norwegian (n= 118) and Swedish (n=53) skiers 
Country 
Cough on 
winter training 
Asthma 
symptomatology 
Bronchial 
hyper-responsiveness 
Current 
asthma 
Norway 
Sweden 
Yes 
No 
Total 
P 
Yes 
No 
Total 
P 
Yes No Yes No Yes No 
32 18 9 41 8 42 
22 46 I 61 3 65 
54 64 16 102 11 107 
0.0006 0.23 0.052 
22 12 16 18 14 20 
5 14 7 12 1 18 
27 26 23 30 15 38 
0.007 0.47 0.005 
Country 
Exacerbation of 
symptoms on 
cold exposure 
Asthma Bronchial 
symptomatology hyper-responsiveness 
Current 
asthma 
Norway 
Sweden 
Yes 
No 
Total 
P 
Yes 
No 
Total 
P 
Yes No Yes No Yes No 
10 6 2 14 2 14 
44 58 14 88 9 93 
54 64 16 102 11 107 
0.14 1.0 0%4 
19 5 11 13 11 13 
8 21 12 17 4 25 
21 26 23 30 15 38 
0.00018 0.74 0.0099 
Results 
RESPIRATORY SYMPTOMS (TABLE 2) 
In both groups, the predominant symptoms were 
wheeze and exercise-related chest tightness within the 
last year, and abnormal shortness of breath on 
exercise and with exposure to airway irritants. 
Wheeze was reported by at least 45% of skiers. Every 
third skier in each group complained of chest 
tightness on exertion within the last year, and breath- 
lessness on exposure to airway irritants. Abnormal 
shortness of breath on exertion was reported by at 
least every fourth skier in each group. Wheeze 
together with attacks of shortness of breath was 
reported by 35% of skiers in both groups. 
Cough on winter training was reported signifi- 
cantly more often by skiers in Sweden than in 
Norway (64% and 42% respectively, PcO.01). Cough 
under other circumstances was infrequent. Exacer- 
bation of symptoms on exposure to cold was three 
times more frequent among Swedish skiers (45% vs. 
14%, P<O.OOl). 
ASTHMA SYMPTOMATOLOGY 
Positive asthma symptomatology was present 
in almost every other skier in both groups (Fig. 1). 
It was associated (Table 3) with cough on winter 
training in both groups (Norway, P<O.OOl, 
Sweden, P<O.Ol), and exacerbation of symptoms 
on exposure to cold conditions in Sweden alone 
(P<O.OOl). 
BRONCHIAL HYPER-RESPONSIVENESS 
Bronchial hyper-responsiveness was three times 
more prevalent in Sweden than in Norway (43% vs. 
14%, P<O.OOl) (Fig. 1). It was not associated with 
cough on winter training, or with exacerbation of 
symptoms on exposure to cold conditions in either 
group (Table 3). One-third of the hyper-responsive 
skiers were asymptomatic, with no differences 
between the countries. 
CURRENT ASTHMA 
The prevalence of current asthma, defined as BHR 
with asthma symptomatology, was three times 
greater in Sweden (28% vs. 9%, PcO.01) (Fig. 1). 
Current asthma was associated with winter cough 
(PcO.01) and with exacerbation of symptoms on 
exposure to cold conditions (P~0.01) in Swedish 
skiers alone (Table 3). 
Asthma and cross-country skiing 103 
Table 4 The absence of association between self-reported respiratory allergy with asthma 
symptomatology, bronchial hyper-responsiveness and current asthma in cross-country skiers 
from Norway (n= 118) and Sweden (n= 53) 
Country 
Self-reported Asthma Bronchial Current 
respiratory allergy symptomatology hyper-responsiveness asthma 
Norway 
Sweden 
Yes 
No 
Total 
P 
Yes 
No 
Total 
P 
Yes No Yes No Yes No 
3 10 3 10 1 12 
51 54 13 92 10 95 
54 64 16 102 11 107 
0.08 0.38 1.0 
8 9 10 7 6 11 
19 17 13 23 9 27 
27 26 23 30 15 38 
0.69 0.11 0.51 
PHYSICIAN CONSULTATION 
Physician consultation rate was significantly 
greater among Swedish skiers than Norwegian skiers 
(40% vs. 24%, PcO.05). Swedish skiers with asthma 
symptoms were more likely to consult their physi- 
cian. Of those skiers with positive asthma symptoma- 
tology, 59% from Sweden (16 skiers) and 35% from 
Norway (19 skiers) had consulted their doctor within 
the preceding 5 yr (PcO.05). 
ASTHMA DIAGNOSIS 
A physician diagnosis of asthma was reported by 
26% and 10% of skiers from Sweden and Norway, 
respectively (PcO.01). 
Of 14 Norwegian skiers fulfilling the criteria for 
current asthma, six skiers had not consulted their 
doctor and an additional three skiers were not diag- 
nosed by their doctor. Of 22 Swedish skiers with 
asthma, seven skiers had not consulted their doctor 
and an additional four skiers were not diagnosed by 
their doctor. 
ANTI-ASTHMATIC MEDICATION 
The use of anti-asthmatic medication within the 
last year was reported by 38% and 16% of Swedish 
and Norwegian skiers, respectively (P<O.Ol). 
The most commonly used drugs in both groups 
were the &agonists, used by 38% and 14% 
of Swedish and Norwegian skiers, respectively 
(P~O.001). Inhaled corticosteroids were used by 23% 
of Swedish skiers and by 4% of Norwegian skiers 
(P<O.OOl). Sodium cromoglycate was used by 4% of 
skiers. 
Bronchodilators were used for symptomatic treat- 
ment. Of 50 (29 Norwegian and 21 Swedish) skiers 
who had consulted their doctor, 34 (15 Norwegian 
and 19 Swedish) used bronchodilator therapy. All 
except three of these skiers (one from Sweden and 
two from Norway) had positive asthma sympto- 
matology. All skiers with current asthma who had 
consulted their doctors were on bronchodilator 
therapy. 
TOTAL ASTHMA 
The prevalence of total asthma, defined as 
physician-diagnosed asthma currently treated with 
corticosteroids (10 skiers) in addition to current 
asthma, was 3.5 times greater in Sweden than in 
Norway (42% vs. 12%, P<O.OOl) (Fig. 1). 
SELF-REPORTED RESPIRATORY ALLERGY 
The prevalence of self-reported allergy was three 
times greater in Sweden than in Norway (32% vs. 
ll%, PO.001) (Fig. 1). However, in both groups, 
self-reported respiratory allergy was independent of 
asthma symptomatology, BHR and current asthma 
(Table 4). 
Discussion 
In this study of young, elite cross-country skiers 
in central Scandinavia, the prevalence of asthma 
symptomatology was similar in both countries. 
However, the prevalence of BHR and asthma was 
three times greater in Swedish than in Norwegian 
skiers. 
It is most unlikely that the differences in prevalence 
of asthma and BHR could be due to methodological 
errors. The protocol and equipment for spirometry 
and measurement of BHR were the same in both 
locations. Furthermore, the instruments were com- 
pared to each other and found to be identical re- 
garding volume measurement (spirometry) and 
methacholine output (Spira Elektro 2 nebulizer). 
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The prevalence of asthma symptomatology in 
these Swedish skiers is twice that found in an earlier 
study of Swedish cross-country skiers (3). The defi- 
nition of asthma symptomatology in these two 
studies was identical. However, the study populations 
were different. The study population in the present 
study were skiers from Central Sweden only, while 
the previous study included skiers from all the ski 
schools in Sweden as well as members of the training 
groups of the national team. 
Asthma symptoms have been reported to occur 
more frequently among cross-country skiers than in 
the general population exposed to similar conditions 
(3). In Northern Sweden where the winter climate is 
cold, the prevalence of asthma symptoms among 
lCyear-olds has been reported to be one-half of that 
found in the present study (5). The frequency of 
wheezing with attacks of breathlessness was five 
times greater in this study than in a recently reported 
study of the general population from this region (6). 
The reasons for the high prevalence of BHR 
among the Swedish skiers are unknown. It is not 
thought that BHR to methacholine was over- 
estimated in the present study as a cut-off point of 
9.1 pmol was used, which is lower than the 13.2 pmol 
chosen by Nieminen et al. (4). Arbitrary cut-off 
points of 6.4 pmol and 7.8 pmol have been chosen in 
other studies (7,8) in which, however, other nebuliz- 
ers were used. Prior to the present study, a compari- 
son was made between the present study method and 
the previously used standardized method as described 
by Juniper et al. (9). A good agreement was found 
with the maximum PD,, dose of 9.1 pmol not exceed- 
ing a dose corresponding to PC,, ~8 mg ml - ’ 
methacholine with the Juniper method (data not 
shown). 
Although the prevalence of self-reported respirat- 
ory allergy was three times higher in Sweden, there 
was no association between BHR and self-reported 
allergy in either group. As atopic individuals have 
been reported to be significantly more responsive to 
methacholine than non-atopic individuals (lo), this 
was unexpected. 
One possible explanation is the differences in the 
winter climatic conditions between the two regions. 
Inhalation of cold, dry air for 10 min by healthy 
individuals results in a transient increase in bronchial 
responsiveness to histamine (11). The volume 
ventilated in 1 min by cross-country skiers can be 
increased 40-fold during hard training and com- 
petition compared to ventilation at rest. It is thus 
possible that the hyperpnoea and exposure to cold air 
may have a cumulative effect on bronchial respon- 
siveness. The Swedish skiers reported a significantly 
higher frequency of exacerbation of respiratory 
symptoms on exposure to cold weather. This was not 
unexpected as the degree of exposure to cold air was 
significantly greater in the Swedish skiers, in terms of 
exposure to a colder climate as well as years of skiing 
experience. 
It is unknown whether the BHR in this cross- 
sectional study of skiers was persistent as found 
previously (2). 
The present definition of current asthma required 
the presence of wheeze and breathlessness or chest 
tightness together with BHR. Wheeze within the 
previous year and BHR has been proposed as a ‘gold 
standard’ for current asthma in epidemiological 
studies (12). The prevalence of current asthma 
using this definition would be 9% and 25% in the 
Norwegian and Swedish skiers, respectively, which is 
very close to that found using the present definition. 
The higher prevalence of current asthma among 
the Swedish skiers was due to differences in bronchial 
responsiveness. The prevalence approached that of 
33% reported in a study of more experienced and 
older Swedish cross-country skiers (2). In a study of 
high-level Norwegian skiers, the prevalence of self- 
reported asthma was 14%, three times greater than 
that of non-skiing controls (1). 
The prevalence of current asthma in teenagers in 
Northern Sweden was one-quarter (5) and in 16-year- 
olds in the county of Jamtland was one-third (13) of 
that found in the present group of Swedish skiers. In 
both studies, the definition of current asthma was 
close to the present definition. Thus the prevalence of 
current asthma in cross-country skiers is greater than 
in the general population exposed to similar climatic 
conditions. 
Anti-asthmatic medication was used mainly for 
symptomatic treatment, especially among Swedish 
skiers. The medication rate was similar to that in 
elite, adult Swedish skiers (2). As a complement to 
medication, non-pharmacological management of 
this type of asthma should be emphasized. Such 
measures include a more liberal use of heat and 
moisture-retaining masks, and avoidance of training 
and competition under extremely low ambient 
temperature conditions. 
In conclusion, there is a high prevalence of BHR 
and asthma among young, elite cross-country skiers 
in central Scandinavia, especially in Sweden. Com- 
petitive cross-country skiing may be a risk factor for 
the development of asthma. Longitudinal studies of 
cross-country skiers, and studies to acquire further 
knowledge of the mechanisms involved in the devel- 
opment of asthma are indicated, as are studies 
exploring the pathophysiology of this type of asthma. 
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